In Korea, as there have been cases of death from 'rare thrombosis' after receiving the AstraZeneca (AZ) COVID-19 vaccine, the quarantine authorities decided to guide the precautions more carefully.

Park Young-joon, head of the adverse reaction investigation team of the Corona 19 Vaccination Response Promotion Team, said, "We are supplementing the system for guiding precautions for vaccinated people in a regular briefing on the 18th. "He said.

In Korea, the AstraZeneca vaccine has been vaccinated only to those over the age of 30 since April of this year.

However, two men in their 30s were recently diagnosed with TTS, and one of them died on the 16th.

Team leader Park said, "We will send text messages to all vaccinated individuals and provide clearer text to promptly visit a medical institution if any suspicious symptoms appear."

He added, "We plan to supplement the system for checking and guiding through the Drug Information Management System (DUR) if suspicious symptoms appear after receiving adenovirus vector vaccines, such as AstraZeneca or Janssen vaccines, in the same way for medical institutions."

The quarantine authorities reconfirmed the policy that it is difficult for individuals to choose a specific vaccine even in the second half of the year.

In response to a related inquiry, Kim Ki-nam, head of the inoculation planning department of the promotion group, said, "The types of vaccines will be diversified in the second half, but in principle, we plan to operate by designating vaccines that are suitable for each subject rather than selecting and inoculating a specific vaccine."said.

In particular, regarding the vaccination process for those in their 40s and younger, Kim said, "For those in their 40s to 18 years old, starting from August, depending on the type or quantity of vaccines that arrive weekly or every 1-2 weeks, reservations will be made in advance. explained.

He said, "I don't think it is possible to directly select a vaccine because the types and quantities of vaccines that will be introduced this week and next week have not been specified." He added, "As in the case of residual vaccines, indirectly or with some exceptions. There are ways to choose a vaccine,” he added.

Regarding the temporary 'cross-vaccination' in July, the quarantine authorities emphasized that there were no serious adverse reactions overall when examining domestic and foreign studies and overseas cases.

Regarding whether to allow cross-vaccination after July, Kim said, "The plan after August will be decided after further review by analyzing the supply and demand situation of AstraZeneca or Pfizer vaccines, domestic and foreign research results, and overseas cases."

(Photo = Yonhap News)